They happen because your body is adjusting to the medications, your appetite becomes low, and you drink less water without noticing it
May your inflammation markers stay low, your protocols stay evidence-based, and your recovery stay steady.
Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist administered subcutaneously for type 2 diabetes management and chronic weight management
16 mg showed 5.0% compared with placebo of 1.3%
The emerging scientific consensus, highlighted by advanced research into oxidative stress and mitochondrial failure, validates what patients have known all along: your cells are fighting a massive, unseen battle at the biochemical level
Ozempic is indicated for diabetes but was widely prescribed off-label for weight loss before the emergence of alternative drugs